SEC Filing Details

Document Details

Filing Date
Sep 16, 2022
Document Date
Nov 10, 2022
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.